Structure and promoter activity of an islet-specific glucose-6- phosphatase catalytic subunit-related gene

Diabetes

Volumn 48, Issue 3, 1999, Pages 543-551

  Ebert, Daniel H ^a   Bischof, Larry J ^a   Streeper, Ryan S ^a   Chapman, Stacey C ^a   Svitek, Christina A ^a   Goldman, Joshua K ^a   Mathews, Clayton E ^b   Leiter, Edward H ^b   Hutton, John C ^c   O'Brien, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE 6 PHOSPHATASE; SOMATOMEDIN C;

ARTICLE; CHROMOSOME 2; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBUNIT; GENE LOCATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

EID: 0033014161     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.543     Document Type: Article

References (71)

1. Flakoll P, Carlson MG, Cherrington A: Physiologic action of insulin. In Diabetes Mellitus. A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds, Philadelphia, PA, Lippincott-Raven, 1996, p. 121-132
2. Cersosimo E, Molina PE, Abumrad NN: Renal lactate metabolism and gluconeogenesis during insulin-induced hypoglycemia. Diabetes 47:1101-1106, 1998
3. Burchell A: Molecular pathology of glucose-6-phosphatase. FASEB J 4:2978-2988, 1990
4. Mithieux G: New knowledge regarding glucose-6 phosphatase gene and protein and their roles in the regulation of glucose metabolism. Eur J Endocrinol 136:137-145, 1997
5. Foster JD, Pederson BA, Nordlie RC: Glucose-6-phosphatase structure, regulation, and function: an update. Proc Soc Exp Biol Med 215:314-332, 1997
6. Lei K-J, Shelly LL, Pan CJ, Sidbury JB, Chou JY: Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 262:580-583, 1993
7. Shelly LL, Lei K-J, Pan C-J, Sakata SF, Ruppert S, Schutz G, Chou JY: Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Biol Chem 268:21482-21485, 1993
8. Gerin I, Veiga-da-Cunha M, Achouri Y, Collet JF, Van Schaftingen E: Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type 1b. FEBS Lett 419:235-238, 1997
9. Waddell ID, Zomerschoe AG, Voice MW, Burchell A: Cloning and expression of a hepatic microsomal glucose transport protein. Biochem J 286:173-177, 1992
10. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM. Diabetes Care 15:318-368, 1992
11. Consoli A: Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430-441, 1992
12. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J Clin Invest 94:2369-2376, 1994
13. Schmoll D, Allan BB, Burchell A: Cloning and sequencing of the 5′ region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells. FEBS Lett 383:63-66, 1996
14. Streeper RS, Svitek CA, Chapman S, Greenbaum LE, Taub R, O'Brien R.M: A multi-component insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem 272:11698-11701, 1997
15. Streeper RS, Eaton EM, Ebert DH, Chapman S, Svitek CA, O'Brien RM: Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription. Proc Natl Acad Sci U S A 95:9208-9213, 1998
16. Efendic S, Karlander S, Vranic M: Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity. J Clin Invest 81:1953-1961, 1988
17. Granner DK, O'Brien RM: Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care 15:369-395, 1992
18. Barzilai N, Rossetti L: Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019-25025, 1993
19. Seoane J, Trinh K, O'Doherty RM, Gomez-Foix AM, Lange AJ, Newgard CB, Guinovart JJ: Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J Biol Chem 272:26972-26977, 1997
20. Burchell A, Cain DI: Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes. Diabetologia 28:852-856, 1995
21. Liu Z, Barrett EJ, Dalkin AC, Zwart AD, Chou JY: Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Commun 205:680-686, 1994
22. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R: High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 95:832-841, 1995
23. Argaud D, Zhang Q, Pan W, Maitra S, Pilkis SJ, Lange AJ: Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states. Diabetes 45:1563-1571, 1996
24. Mithieux G, Vidal H, Zitoun C, Bruni N, Daniele N, Minassian C: Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45:891-896, 1996
25. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L: Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 271:9871-9874, 1996
26. Polonsky KS: The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717, 1995
27. Poitout V, Robertson RP: An integrated view of beta-cell dysfunction in type-II diabetes. Ann Rev Med 47:69-83, 1996
28. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
29. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, Froguel P, Cohen D: Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721-722, 1992
30. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre J-C, Froguel P, Bell GI: Mutations in the hepatocyte nuclear factor-lalpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
31. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
32. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17:384-385, 1997
33. Bell GI, Pilkis SJ, Weber IT, Polonsky KS: Glucokinase mutations, insulin secretion, and diabetes mellitus. Ann. Rev Physiol 58:171-186, 1996
34. Arden SD, Zahn T, Steegers S, Webb S, Bergman B, O'Brien RM, Hutton JC: Molecular cloning of a pancreatic islet specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes 48:531-542, 1999
35. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI: Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457, 1995
36. Khan A, Chandramouli V, Ostenson CG, Low H, Landau BR, Efendic S: Glucose cycling in islets from healthy and diabetic rats. Diabetes 39:456-459, 1990
37. Khan A, Hong-Lie C, Landau HR: Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone. Endocrinology 136:1934-1938, 1995
38. Trinh K, Minassian C, Lange AJ, O'Doherty RM, Newgard CB: Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in INS-1 cells. Effects on glucose cycling, glucose usage, and insulin secretion. J Biol Chem 272:24837-24842, 1997
39. Printz RL, Koch S, Potter LR, O'Doherty RM, Tiesinga JJ, Moritz S, Granner DK: Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. J Biol Chem 268-5209-5219, 1993
40. Rowe L, Nadeau JH, Turner R, Frankel WN, Letts VA, Eppig JT, Ko MSH, Thurston SJ, Birkenmeier EH: Maps from two interspecific backcross DNA panels as a community mapping resource. Mamm Genome 5:253-274, 1994
41. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
42. Chrapkiewicz NB, Beale EG, Granner DK: Induction of the messenger ribonucleic acid coding for phosphoenolpyruvate carboxykinase in H4-II-E cells. Evidence for a nuclear effect of cyclic AMP. J Biol Chem 257:14428-14432, 1982
43. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
44. Forest CD, O'Brien RM, Lucas PC, Magnuson MA, Granner DK: Regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence. Mol Endocrinol 4:1302-1310, 1990
45. Jacoby DB, Zilz ND, Towle HC: Sequences within the 5′-flanking region of the S14 gene confer responsiveness to glucose in primary hepatocytes. J Biol Chem 264:17623-17626, 1989
46. O'Brien RM, Lucas PC, Yamasaki T, Noisin EL, Granner DK: Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through C/EBP. J Biol Chem 269:30419-30428, 1994
47. O'Brien RM, Noisin EL, Suwanickul A, Yamasaki T, Lucas PC, Wang J-C, Powell DR, Granner DK: Hepatic nuclear factor-3 and hormone regulated expression of the PEPCK and IGFBP-1 genes. Mol Cell Biol 15:1747-1758, 1995
48. O'Brien RM, Halmi N, Printz RL, Granner DK: Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochem Biophys Acta 1264:284-288, 1995
49. Jackson IJ: A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res 19:3795-3798, 1991
50. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R: High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 95:832-841, 1995
51. Lei KJ, Pan CJ, Shelly LL, Liu JL, Chou JY: Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Clin Invest 93:1994-1999, 1994
52. Annabi B, Hiraiwa H, Mansfield BC, Lei KJ, Ubagai T, Polymeropoulos MH, Moses SW, Parvari R, Hershkovitz E, Mandel H, Fryman M, Chou JY: The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 62:400-405, 1998
53. Fenske CD, Jeffery S, Weber JL, Houlston RS, Leonard JV, Lee PJ: Localisation of the gene for glycogen storage disease type 1c by homozygosity mapping to 11q. J Med Genet 35:269-272, 1998
54. Lin B, Morris DW, Chou JY: The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation. Biochemistry 36:14096-14106, 1997
55. Shelton KD, Franklin AJ, Khoor A, Beechem J, Magnuson MA: Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Mol Cell Biol 12:4578-4589, 1992
56. Sander M, German MS: The beta cell transcription factors and development of the pancreas. J Mol Med 75:327-340, 1997
57. Hussain MA, Lee J, Miller CP, Habener JK: POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Mol Cell Biol 17:7186-7194, 1997
58. Wang M, Drucker DJ: Activation of amylin gene transcription by LIM domain homeobox gene isl-1. Mol Endocrinol 10:243-251, 1996
59. Lange AJ, Argaud D, el-Maghrabi MR, Pan W, Maitra SR, Pilkis SJ: Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun 201:302-309, 1994
60. Massillon D, Chen W, Barzilai N, Prus-Wertheimer D, Hawkins M, Liu R, Taub R, Rossetti L: Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J Biol Chem 273:228-234, 1998
61. Argaud D, Kirby TL, Newgard CB, Lange AJ: Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate. J Biol Chem 272:12854-12861, 1997
62. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L: Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46:153-157, 1997
63. Chatelain F, Pegorier JP Minassian C, Bruni N, Tarpin S, Girard J, Mithieux G: Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes 47:882-889, 1998
64. Metzger S, Goldschmidt N, Barash V, Peretz T, Drize O, Shilyansky J, Shiloni E, Chajek-Shaul T: Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am J Physiol 273: E262-E267, 1997
65. Metzger S, Begleibter N, Barash V, Drize O, Peretz T, Shiloni E, Chajek-Shaul T: Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro. Metabolism 46:579-583, 1997
66. Magnuson MA: Glucokinase gene structure. Functional implications of molecular genetic studies. Diabetes 39:523-527, 1990
67. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest 101:2215-2222, 1998
68. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575-585, 1996
69. Lee YH, Sauer B, Gonzalez FJ: Laron dwarfism and non-bisulin-dependent diabetes mellitus in the HNF-1α knockout mouse. Mol Cell Biol 18:3059-3068, 1998
70. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510, 1996
71. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F: Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489-2495, 1995